The same, however, was not observed for the 4R tau aggregates typical of primary tauopathies, such as PSP or CBD, where post-mortem results are more heterogeneous and overall present less robust staining137–142. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.